Biophytis, a start-up based in Romainville (Seine St Denis) in the biopark Biocitech, was created in 2006 by Stanislas Veillet and René Lafont, a Professor at Université Pierre et Marie Curie. It
develops a portfolio of nutraceuticals and drug candidates derived from active natural substances targeted at metabolic disorders and age related diseases. This strategy allows to identify drug
candidates from actives already clinically tested, hence reducing the clinical risk, and to develop nutraceuticals compliant with new european ruling on health claims. Its portfolio includes two
proprietary actives clinicaly tested : Quinolia® : obesity treatment and Bixilia® : skin protection against UV radiations. It also includes two drug candidates at pre-clinical stage in the fields of
sarcopenic obesity and age related macular degeneration. Biophytis co-owns a portfolio of five patents with Université Pierre et Marie Curie. Its aim is to sign research and licensing agreements
with companies of the pharmaceutical and nutrition industry.